Login to My NLA Account

test

 

Elevate your expertise in lipidology with Mastering Triglyceride Science: An In-Depth Master’s Course – a cutting-edge, master’s-level course series designed to bridge knowledge, competence, and practice gaps in hypertriglyceridemia management. This intensive, two-day program provides an unparalleled opportunity to deepen your understanding of severe hypertriglyceridemia, its complex pathophysiology, and the latest therapeutic strategies. Gain advanced proficiency in lipid science and enhance your ability to guide patients in making informed decisions about triglyceride-lowering therapies to mitigate the risk of life-threatening complications.

Why Attend?

  • Cutting-Edge Science: Stay ahead with the latest evidence-based research on triglyceride disorders, therapeutic targets, and emerging treatments.

  • Expert-Led Education: Learn from leading lipidologists and researchers at the forefront of triglyceride science.

  • Practical Application: Enhance your clinical acumen with real-world strategies to manage hypertriglyceridemia effectively.

  • Flexible Learning: Join us in person or virtually at our two premier NLA events in 2026.

When & Where?

Who Should Attend?

This advanced course is tailored for lipid specialists looking to refine their expertise in triglyceride management, including:

  • Lipidologists & Preventive Cardiologists

  • Allied Health Lipid Specialists

  • Researchers & Clinicians Focused on Lipid Science

  • Healthcare Professionals with Advanced Knowledge in Lipidology

What You Will Gain

By participating in this master’s-level course, you will:

  • Strengthen your knowledge and competence in severe hypertriglyceridemia.

  • Explore the complexities of lipid science and cutting-edge research.

  • Develop a strategic approach to triglyceride-lowering therapies, including novel treatment options.

  • Enhance patient care with evidence-based solutions to reduce the risk of extreme complications from severe hypertriglyceridemia.

Join Us and Advance Your Expertise

Don’t miss this exclusive, high-level educational opportunity designed to refine your skills, deepen your knowledge, and position you as a leader in lipidology. Secure your spot today and take the next step in mastering triglyceride science!

At the conclusion of this activity, participants should be able to:

 
  • Describe the processes of triglyceride synthesis, secretion, and clearance.
  • Identify key pharmaceutical targets for treatment in relation to disease management.
  • Differentiate the clinical and genetic characteristics of Familial Chylomicronemia Syndrome (FCS), Multifactorial Chylomicronemia Syndrome (MCS), and Lipodystrophies.
  • Evaluate existing and emerging evidence-based treatment options for hypertriglyceridemia, with a focus on pancreatitis risk reduction.
  • Explain the mechanisms involved in hypertriglyceridemic pancreatitis and demonstrate the steps for accurate diagnosis and appropriate treatment.
  • Assess the impact of remnant lipoproteins on ASCVD risk and develop management strategies based on current evidence.
  • Identify dietary interventions tailored to specific triglyceride levels to optimize patient health and reduce cardiovascular or pancreatitis risk.
  • Enhance the healthcare team's approach by applying insights from interactive case discussions and best practice sharing.

Accreditation details will be updated soon.

Zahid Ahmad, MD, FNLA | Course Co-Chair
Associate Professor of Internal Medicine
Lipid Section, Division of Endocrinology
UT Southwestern Medical Center
Director, Parkland Lipid Clinic
Co-Director, UT Southwestern Familial Hypercholesterolemia Clinic
Dallas, TX
 
Savitha Subramanian, MD | Course Co-Chair

Medical Director, Lipid Clinic
Division of Metabolism, Endocrinology and Nutrition
University of Washington
Seattle, WA

Dave L. Dixon, PharmD, FNLA, CLS

Nancy and Ronald McFarlane Professor of Pharmacy
Chair, Department of Pharmacotherapy & Outcomes Science
Virginia Commonwealth University School of Pharmacy
Richmond, VA

Robert H. Eckel, MD, FNLA

Professor of Medicine, Emeritus
Division of Endocrinology, Metabolism and Diabetes
Division of Cardiology
S/P Professor of Physiology & Biophysics
S.P Charles A. Boettcher Chair in Atherosclerosis
University of Colorado Anschutz Medical Campus
Aurora, CO

Abhimanyu Garg, MD

Professor of Internal Medicine, Chief, Section of Nutrition and Metabolic Diseases, Division of Endocrinology
UT Southwestern Medical Center
Dallas, TX

Vikesh K. Singh, MD, MSc

Professor of Medicine and Director of Pancreatology
Division of Gastroenterology
Johns Hopkins University School of Medicine
Director of Endoscopy, Johns Hopkins Hospital

Lauren Williams, MCN, RDN, LD

Clinical Dietitian II
Pediatric Cardiology 
Baylor Scott & White – McLane Children’s Medical Center
Temple, TX

The agenda will be updated throughout the planning process as new information and outcomes data is released.

Wednesday, June 10, 2026

Day 1

10:00 AM - 10:15 AM Welcome | Pre-test Zahid Ahmad, MD, FNLA | Course Co-Chair
10:15 AM - 10:55 AM Physiology of Triglyceride Synthesis and Secretion Abhimanyu Garg, MD
10:55 AM - 11:30 AM Triglyceride Lipolysis/Clearance Robert H. Eckel, MD, FNLA
11:30 AM - 12:00 PM Question + Answer
12:00 PM - 12:35 PM Lunch
12:35 PM - 1:00 PM Multifactorial Chylomicronemia Syndrome Zahid Ahmad, MD, FNLA
1:00 PM - 1:40 PM Familial Chylomicronemia Syndrome Robert H. Eckel, MD, FNLA
1:40 PM - 2:00 PM Question + Answer
2:00 PM - 2:15 PM Break
2:15 PM - 2:45 PM Lipodystrophies Abhimanyu Garg, MD
2:45 PM - 3:00 PM Question + Answer
3:00 PM - 4:00 PM Interactive Patient Cases | Roundtable Discussion All Speakers from Day 1, moderated by Savitha Subramanian, MD | Course Co-Chair

Thursday, June 11, 2026

Day 2

7:30 AM - 8:00 AM Breakfast
8:00 AM - 8:10 AM Days Overview
8:10 AM - 9:10 AM Mechanism, Diagnosis, and Treatment of Hypertriglyceridemic Pancreatitis Vikesh K. Singh, MD, MSc
9:10 AM - 9:40 AM Mechanism, Diagnosis, and Treatment of Increased ASCVD Risk from Remnant Lipoproteins Robert H. Eckel, MD, FNLA
9:40 AM - 10:15 AM Dietary Treatment for Hypertriglyceridemia to Reduce ASCVD Risk and/ or Pancreatitis Risk Lauren Williams, MCN, RDN, LD
10:15 AM - 10:30 AM Question + Answer
10:30 AM - 10:45 AM Break
10:45 AM - 11:35 AM Current and Future Pharmacologic Treatments for Hypertriglyceridemia Dave L. Dixon, PharmD, FNLA, CLS
11:35 AM - 11:45 AM Question + Answer
11:45 AM - 12:45 PM Interactive Patient Cases | Roundtable Discussion | Tips & Tricks All Speakers from Day 2, moderated by  Zahid Ahmad, MD, FNLA | Course Co-Chair
12:45 PM - 1:00 PM Post-Test